The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
Department of Pathological Sciences, Division of Molecular Pathology, University of Manchester, UK.
Neuroscience letters 1997;221(2-3):81-4.
The effect of apolipoprotein E (ApoE) genotype on the deposition of amyloid beta protein (Abeta) was examined in 54 patients with Alzheimer's disease. No difference in the amount of Abeta deposited as Abeta42(43) was seen between genotype groups with no, one or two E4 alleles. However, the amount of Abeta40 deposited increased according to the copy number of E4 alleles with patients possessing one E4 allele containing more than twice, and those with two E4 alleles, four times, the amount of Abeta40 in their brains compared to patients without an E4 allele. The increase in total Abeta deposited within the tissue (i.e. Abeta40 plus Abeta42(43) loads) in the presence of an E4 allele is therefore due entirely to an enhanced deposition of Abeta40. These data are consistent with the suggestion that the presence of E4 within pre-existing Abeta42(43) containing plaques may lower the threshold to fibrilization of Abeta40 thereby promoting its subsequent deposition. Thus, although the total amount of Abeta initially deposited in the brain as Abeta42(43) is not affected by the binding of any one particular ApoE isoform this does influence the subsequent maturation of plaques with a greater proportion transforming into Abeta40 containing cored plaques when the E4 isoform is present.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
COLE, GREGORY M
1 September 2011 - 31 March 2016
NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE
Total Funding: $ 766,150
1 February 1989 - 30 June 2009
NATIONAL INSTITUTE ON AGING
Total Funding: $ 40,531,208
HYMAN, BRADLEY T
30 September 2009 - 31 August 2011
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,039,362
K Ishii; A Tamaoka; H Mizusawa; S Shoji; T Ohtake; P E Fraser; H Takahashi; S Tsuji; M Gearing; T Mizutani; et al.Brain research 1997;748(1-2):250-2.
H Yamaguchi; S Sugihara; A Ogawa; N Oshima; Y IharaJournal of neuropathology and experimental neurology 2001;60(7):731-9.
Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; David S Knopman; Leslie M Shaw; John Q Trojanowski; Paul S Aisen; Michael Weiner; Ronald C Petersen; Clifford R Jack; et al.Annals of neurology 2010;67(3):308-16.
Appears in this Publication
Author of this Publication